Adapted Physical Activity and Prevention of Cardiovascular Risk in Elderly People Living With HIV:Comparative Study
NCT ID: NCT05201417
Last Updated: 2022-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2019-09-15
2020-06-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
South Africa Smoking Cessation and Engagement in HIV/TB Care Care
NCT05842161
Examining HIV Treatment Adherence During Early Disease
NCT02419066
Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa
NCT03711721
Ugandan Non-Communicable Diseases and Aging Cohort
NCT02445079
Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy
NCT01539005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
participants and methods: Investigators will conduct a comparative study that involved subjects aged from 50 years and above, recruited from June 2019 to June 2020 at Mvog Ada district hospital
This study will be conducted in 3 phases:
* Phase 1: All eligible adults aged 50 years and older presenting to one of the investigative centers (for HIV care) will be included in the study. The standardized program of adapted physical activity is proposed on the basis of the specifications of adapted physical activities. The participants will be randomized in two parallel groups according to the 1:1 ratio, namely a control group A where participants continue their usual HIV management, and an intervention group B where in addition to the usual HIV management, participants will benefit from an adapted physical activity program. Information regarding heart rate variability and ANS dysfunction will be collected via an overnight recording with the NeuroCoach device (recording box). A questionnaire (to determine the level of physical activity, on compliance with current treatment and quality of life) will be administered.
* Second phase: intervention phase The adapted physical activity program will be offered systematically to all participants in group B. The standardized program of adapted physical activity is proposed on the basis of the specifications of adapted physical activities. An evaluation of heart rate variability, response to current treatment, gut microbiota profile and quality of life will be performed at the end of the APA sessions. Comparison between control group A and intervention group B will be performed.
* The third phase: post-program follow-up: six months At the end of the intervention phase, post-program follow-up will be done through interviews until six months after the end of the intervention. All the participants included will be able to benefit, at their request, a counseling session related to the adapted physical activity program, in order to reinforce integration of physical activity into their day to day routine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group A
patients continue their usual HIV management no intervention
No interventions assigned to this group
intervention group B
patients continue their usual HIV management, patients will benefit from an adapted physical activity program for 12 weeks
adapted physical activity
The adapted physical activity will be administered remotely through the whatsApp or YouTube application. Two sessions will be done per week: Wednesday and Sunday. Walking seems to be appropriate for all participants We will account for 24 APA sessions. We will leverage the Step Tracker phone app and pedometer to get the number of steps done, number of calories spent, Workout duration and distance walked per participant per APA session; this data will be collected weekly (after every two sessions)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
adapted physical activity
The adapted physical activity will be administered remotely through the whatsApp or YouTube application. Two sessions will be done per week: Wednesday and Sunday. Walking seems to be appropriate for all participants We will account for 24 APA sessions. We will leverage the Step Tracker phone app and pedometer to get the number of steps done, number of calories spent, Workout duration and distance walked per participant per APA session; this data will be collected weekly (after every two sessions)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People living with HIV in one of the 2 study'countries;
* People without medical contraindications to participate in moderate physical activity
* People who has received information about the study and its rights to its data.
Exclusion Criteria
* Having a contraindication to physical activity (medical certificate);
* Infected with HIV-2 alone;
* Hospitalized, in end of life care;
* Morbidly obese (BMI \> 40).
50 Years
77 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Support and Education Technic Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bienvenu BONGUE
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric ROCHE, professor
Role: STUDY_CHAIR
5. University Jean Monnet, St Etienne, Laboratory SNA-EPIS EA 4607, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mvog Ada district Hospital
Yaoundé, Centre Region, Cameroon
CHU Saint-Etienne
Saint-Etienne, , France
CHU Saint étienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UJM_UB_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.